Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

被引：10

作者：

Elshaer, Amani ^{[1
]}

Chascsa, David M. H. ^{[2
,3
]}

Lizaola-Mayo, Blanca C. ^{[2
,3
]}

机构：

[1] Mayo Clin, Dept Internal Med, Scottsdale, AZ 85054 USA

[2] Mayo Clin, Div Gastroenterol & Hepatol, Scottsdale, AZ 85054 USA

[3] Mayo Clin, Transplant Ctr, Dept Med, Scottsdale, AZ 85054 USA

来源：

LIFE-BASEL | 2024年 / 14卷 / 07期

关键词：

metabolic-associated steatotic liver disease; fibrosis; cirrhosis; obesity; weight loss; lifestyle modification; pharmacotherapy; bariatric surgery; LIFE-STYLE MODIFICATION; CLINICAL-PRACTICE UPDATE; GLUCAGON-LIKE PEPTIDE-1; CORONARY-HEART-DISEASE; FATTY LIVER; BARIATRIC SURGERY; INSULIN-RESISTANCE; WEIGHT-LOSS; NONALCOHOLIC STEATOHEPATITIS; AMERICAN ASSOCIATION;

D O I：

10.3390/life14070844

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a liver disorder characterized by steatosis with underlying metabolic risk factors. The prevalence of MASLD continues to rise, leading to increased patient risk of various complications. Recent research has been focused on new therapeutic strategies to reduce the incidence of MASLD and provide effective treatment plans to prevent further irreversible liver damage. The treatment approach is multifactorial, with a primary focus on weight loss and management of underlying comorbidities through lifestyle modifications, pharmacotherapy, or surgical options. Ongoing research is exploring new pharmacological therapies that could enhance the treatment of MASLD.

引用

页数：21

共 113 条

[1]

Abdelbasset WK, 2019, MEDICINE, V98, DOI [10.1097/MD.0000000000014918, 10.1097/md.0000000000014918]

[2] Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis [J].

Aithal, Guruprasad P. ;

Thomas, James A. ;

Kaye, Philip V. ;

Lawson, Adam ;

Ryder, Stephen D. ;

Spendlove, Ian ;

Austin, Andrew S. ;

Freeman, Jan G. ;

Morgan, Linda ;

Weeber, Jonathan .

GASTROENTEROLOGY, 2008, 135 (04) :1176-1184

[3] The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study [J].

Allen, Alina M. ;

Hicks, Stephen B. ;

Mara, Kristin C. ;

Larson, Joseph J. ;

Therneau, Terry M. .

JOURNAL OF HEPATOLOGY, 2019, 71 (06) :1229-1236

[4] Glucagon-like peptide 1 in health and disease [J].

Andersen, Andreas ;

Lund, Asger ;

Knop, Filip K. ;

Vilsboll, Tina .

NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (07) :390-403

[5] Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery [J].

Anty, Rodolphe ;

Marjoux, Sophie ;

Iannelli, Antonio ;

Patouraux, Stephanie ;

Schneck, Anne-Sophie ;

Bonnafous, Stephanie ;

Gire, Camille ;

Amzolini, Anca ;

Ben-Amor, Imed ;

Saint-Paul, Marie-Christine ;

Marine-Barjoan, Eugenia ;

Pariente, Alexandre ;

Gugenheim, Jean ;

Gual, Philippe ;

Tran, Albert .

JOURNAL OF HEPATOLOGY, 2012, 57 (05) :1090-1096

[6] Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease [J].

Armandi, Angelo ;

Bugianesi, Elisabetta .

EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 :20-27

[7] Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study [J].

Armstrong, Matthew James ;

Gaunt, Piers ;

Aithal, Guruprasad P. ;

Barton, Darren ;

Hull, Diana ;

Parker, Richard ;

Hazlehurst, Jonathan M. ;

Guo, Kathy ;

Abouda, George ;

Aldersley, Mark A. ;

Stocken, Deborah ;

Gough, Stephen C. ;

Tomlinson, Jeremy W. ;

Brown, Rachel M. ;

Huebscher, Stefan G. ;

Newsome, Philip N. .

LANCET, 2016, 387 (10019) :679-690

[8] Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis [J].

Athyros, Vasilios G. ;

Tziomalos, Konstantinos ;

Gossios, Thomas D. ;

Griva, Theodora ;

Anagnostis, Panagiotis ;

Kargiotis, Konstantinos ;

Pagourelias, Efstathios D. ;

Theocharidou, Eleni ;

Karagiannis, Asterios ;

Mikhailidis, Dimitri P. .

LANCET, 2010, 376 (9756) :1916-1922

[9] Effect of exercise on hepatic steatosis: Are benefits seen without dietary intervention? A systematic review andmeta-analysis [J].

Baker, Callum John ;

Martinez-Huenchullan, Sergio Francisco ;

D'Souza, Mario ;

Xu, Yu ;

Li, Mian ;

Bi, Yufang ;

Johnson, Nathan Anthony ;

Twigg, Stephen Morris .

JOURNAL OF DIABETES, 2021, 13 (01) :63-77

[10] Fructose as a key player in the development of fatty liver disease [J].

Basaranoglu, Metin ;

Basaranoglu, Gokcen ;

Sabuncu, Tevfik ;

Senturk, Hakan .

WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (08) :1166-1172

← 1 2 3 4 5 6 7 8 9 10 →